| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.41B | — | +15.6% |
| Cost of Revenue | $717.8M | — | +15.9% |
| Gross Profit | $695.0M | — | +15.2% |
| R&D Expense | $98.9M | — | +12.9% |
| SG&A Expense | $116.2M | — | +22.4% |
| Operating Income | $164.5M | — | +13.5% |
| Pre-tax Income | $147.6M | — | +1.4% |
| Income Tax | $26.1M | — | -5.7% |
| Net Income | $121.5M | — | +3.1% |
| EPS (Basic) | $0.86 | — | +2.4% |
| EPS (Diluted) | $0.85 | — | +2.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $511.8M | -34.2% | — |
| Accounts Receivable | $1.48B | -11.5% | — |
| Inventory | $1.03B | +3.2% | — |
| Current Assets | $3.26B | -9.7% | — |
| Total Assets | $5.02B | -6.2% | — |
| Current Liabilities | $1.37B | -22.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$156.3M | — | -184.9% |
| Capital Expenditures | $33.9M | — | +3.8% |
| Investing Cash Flow | -$38.4M | — | -4.2% |
| Financing Cash Flow | -$69.2M | — | -35.2% |
| Free Cash Flow | -$190.2M | — | -117.3% |
| Long-term Debt | $687.0M | -1.4% | — |
| Total Liabilities | $2.26B | -15.6% | — |
| Stockholders' Equity | $2.76B | +3.2% | +35.6% |